Chia-Feng Liu1, Armen Abnousi2, Peter Bazeley2, Ying Ni3, Michael Morley4, Christine S Moravec1, Ming Hu2, W H Wilson Tang5. 1. Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, USA. 2. Quantitative Health Sciences, Lerner Research Institute, USA. 3. Taussig Cancer Institute, Heart and Vascular Institute, Cleveland Clinic, OH, USA. 4. University of Pennsylvania, Philadelphia, PA, USA. 5. Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, USA; Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, OH, USA. Electronic address: tangw@ccf.org.
Abstract
BACKGROUND: Acetylation and methylation of histones alter the chromatin structure and accessibility that affect transcriptional regulators binding to enhancers and promoters. The binding of transcriptional regulators enables the interaction between enhancers and promoters, thus affecting gene expression. However, our knowledge of these epigenetic alternations in patients with heart failure remains limited. METHODS AND RESULTS: From the comprehensive analysis of major histone modifications, 3-dimensional chromatin interactions, and transcriptome in left ventricular (LV) tissues from dilated cardiomyopathy (DCM) patients and non-heart failure (NF) donors, differential active enhancer and promoter regions were identified between NF and DCM. Moreover, the genome-wide average promoter signal is significantly lower in DCM than in NF. Super-enhancer (SE) analysis revealed that fewer SEs were found in DCM LVs than in NF ones, and three unique SE-associated genes between NF and DCM were identified. Moreover, SEs are enriched within the genomic region associated with long-range chromatin interactions. The differential enhancer-promoter interactions were observed in the known heart failure gene loci and are correlated with the gene expression levels. Motif analysis identified known cardiac factors and possible novel players for DCM. CONCLUSIONS: We have established the cistrome of four histone modifications and chromatin interactome for enhancers and promoters in NF and DCM tissues. Differential histone modifications and enhancer-promoter interactions were found in DCM, which were associated with gene expression levels of a subset of disease-associated genes in human heart failure.
BACKGROUND: Acetylation and methylation of histones alter the chromatin structure and accessibility that affect transcriptional regulators binding to enhancers and promoters. The binding of transcriptional regulators enables the interaction between enhancers and promoters, thus affecting gene expression. However, our knowledge of these epigenetic alternations in patients with heart failure remains limited. METHODS AND RESULTS: From the comprehensive analysis of major histone modifications, 3-dimensional chromatin interactions, and transcriptome in left ventricular (LV) tissues from dilated cardiomyopathy (DCM) patients and non-heart failure (NF) donors, differential active enhancer and promoter regions were identified between NF and DCM. Moreover, the genome-wide average promoter signal is significantly lower in DCM than in NF. Super-enhancer (SE) analysis revealed that fewer SEs were found in DCM LVs than in NF ones, and three unique SE-associated genes between NF and DCM were identified. Moreover, SEs are enriched within the genomic region associated with long-range chromatin interactions. The differential enhancer-promoter interactions were observed in the known heart failure gene loci and are correlated with the gene expression levels. Motif analysis identified known cardiac factors and possible novel players for DCM. CONCLUSIONS: We have established the cistrome of four histone modifications and chromatin interactome for enhancers and promoters in NF and DCM tissues. Differential histone modifications and enhancer-promoter interactions were found in DCM, which were associated with gene expression levels of a subset of disease-associated genes in humanheart failure.
Authors: Xin Zhou; Brett Maricque; Mingchao Xie; Daofeng Li; Vasavi Sundaram; Eric A Martin; Brian C Koebbe; Cydney Nielsen; Martin Hirst; Peggy Farnham; Robert M Kuhn; Jingchun Zhu; Ivan Smirnov; W James Kent; David Haussler; Pamela A F Madden; Joseph F Costello; Ting Wang Journal: Nat Methods Date: 2011-11-29 Impact factor: 28.547
Authors: Sarah Franklin; Todd Kimball; Tara L Rasmussen; Manuel Rosa-Garrido; Haodong Chen; Tam Tran; Mickey R Miller; Ricardo Gray; Shanxi Jiang; Shuxun Ren; Yibin Wang; Haley O Tucker; Thomas M Vondriska Journal: Am J Physiol Heart Circ Physiol Date: 2016-09-23 Impact factor: 4.733
Authors: Irina Solovei; Audrey S Wang; Katharina Thanisch; Christine S Schmidt; Stefan Krebs; Monika Zwerger; Tatiana V Cohen; Didier Devys; Roland Foisner; Leo Peichl; Harald Herrmann; Helmut Blum; Dieter Engelkamp; Colin L Stewart; Heinrich Leonhardt; Boris Joffe Journal: Cell Date: 2013-01-31 Impact factor: 41.582
Authors: Enis Afgan; Dannon Baker; Bérénice Batut; Marius van den Beek; Dave Bouvier; Martin Cech; John Chilton; Dave Clements; Nate Coraor; Björn A Grüning; Aysam Guerler; Jennifer Hillman-Jackson; Saskia Hiltemann; Vahid Jalili; Helena Rasche; Nicola Soranzo; Jeremy Goecks; James Taylor; Anton Nekrutenko; Daniel Blankenberg Journal: Nucleic Acids Res Date: 2018-07-02 Impact factor: 16.971
Authors: Chukwuemeka G Anene-Nzelu; Mick C J Lee; Wilson L W Tan; Albert Dashi; Roger S Y Foo Journal: Nat Rev Cardiol Date: 2021-08-11 Impact factor: 32.419
Authors: Chia-Feng Liu; Ying Ni; Christine S Moravec; Michael Morley; Euan A Ashley; Thomas P Cappola; Kenneth B Margulies; W H Wilson Tang Journal: Circ Genom Precis Med Date: 2021-02-01
Authors: Chia-Feng Liu; Ying Ni; Varun Thachil; Michael Morley; Christine S Moravec; Wai Hong Wilson Tang Journal: Transl Res Date: 2021-10-22 Impact factor: 7.012